26.12.2012 Views

Toxicology of Industrial Compounds

Toxicology of Industrial Compounds

Toxicology of Industrial Compounds

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

medicines, agrochemicals and food additives. They may be sufficient to<br />

detect potent toxicity but not comprehensive enough to allow presumption<br />

<strong>of</strong> the absence <strong>of</strong> hazard, especially as the base set does not include tests<br />

for reproductive toxicity (Table 20.2).<br />

As production volume increases, more extensive testing should be<br />

undertaken. Often, this has been neglected, prompting the development <strong>of</strong><br />

the OECD guidelines 421 and 422. These tests were intended to recover a<br />

situation that never should have arisen.<br />

A better approach?<br />

There is no question that evaluation for reproductive toxicity could be<br />

improved considerably. The question is whether industry and agencies are<br />

willing to do so. It would require a change <strong>of</strong> attitude in industry and<br />

agencies alike. Industry’s ‘passive avoidance’ <strong>of</strong> testing would need to be<br />

replaced by ‘active participation’. For a new substance the first step should<br />

be an integrated assessment <strong>of</strong> commercial prospects and potential toxicity<br />

over a broad spectrum (Figure 20.1). Early identification <strong>of</strong> ‘serious bad<br />

actors’, which tend to effect many systems, can save time and effort. Given<br />

the prognosis <strong>of</strong> problems ahead, it may be better to devote resources to<br />

finding safer alternatives, or to risk management, rather than to endless<br />

testing. For materials with a high commercial potential, the aim should be<br />

to get to full scale tests by the quickest route. Following the EC levels by rote<br />

is very inefficient since there is duplication with successive steps.<br />

Methods<br />

With an active participation policy, a much broader scope <strong>of</strong> methodology<br />

can and should be considered, ranging from searches for structure-activity<br />

relationships, through various in vitro methods, whole animal tests, wild<br />

life surveys and human surveys (Table 20.3). Due to time constraints I will<br />

concentrate on whole animal test systems.<br />

Structure-activity databases<br />

Structure and activity relationships are an obvious place to start any<br />

evaluation, despite the fact that currently available databases are far from<br />

perfect. Their reliability could be improved dramatically by adding unused<br />

information currently hidden in industry and agency archives.<br />

Entire mammalian tests<br />

A.K.PALMER 283<br />

Tests in entire mammals provide the only way <strong>of</strong> assessing what effects a<br />

substance may evoke in the complex, integrated and dynamic process <strong>of</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!